 |
|
Effect of Surgical Adhesion Reduction Devices on the Propagation of Experimental Intra-abdominal Infection
Arthur O. Tzianabos, PhD;
Ronald L. Cisneros, MS;
Julia Gershkovich, MS;
Jeff Johnson, MS;
Robert J. Miller, PhD;
James W. Burns, PhD;
Andrew B. Onderdonk, PhD
Arch Surg. 1999;134:1254-1259.
Hypothesis The use of certain surgical adhesion reduction devices where there is a risk of concomitant bacterial contamination potentiates intra-abdominal infection.
Design Evaluation of adhesion reduction devices in an experimental model of intra-abdominal infection.
Setting Experimental animal model.
Interventions Adhesion reduction devices were administered at the time of bacterial challenge.
Main Outcome Measures Animal mortality rate, abscess formation, and bacterial counts in peritoneal fluid and blood cultures.
Results The use of bioresorbable membrane adhesion reduction devices in the presence or absence of antibiotic therapy did not alter the disease process as compared with appropriate control groups. However, adhesion reduction gels prepared from sodium hyaluronate and carboxymethylcellulose chemically modified with carbodiimide or ferric ion complexed sodium hyaluronate increased the incidence of peritonitis in treated animals. Gel formulations containing diimide-modified carboxymethylcellulose did not have this effect.
Conclusions The use of certain adhesion reduction devices resulted in the propagation of intra-abdominal infection in an experimental rat model. This outcome was dependent on the composition of the device employed. The use of adhesion reduction devices should be tested in appropriate models of infection where there is the risk of concomitant bacterial contamination.
From Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (Drs Tzianabos and Onderdonk and Mr Cisneros); and Genzyme Corp, Cambridge, Mass (Drs Miller and Burns, Ms Gershkovich, and Mr Johnson). Dr Tzianabos and Dr Onderdonk do not hold an equity position in Genzyme Corp, but do serve as consultants. Ms Gershkovich, Mr Johnson, and Drs Miller and Burns are all employees of Genzyme Corp.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Surface Treatment of Flexor Tendon Autografts with Carbodiimide-Derivatized Hyaluronic Acid. An in Vivo Canine Model
Zhao et al.
JBJS 2006;88:2181-2191.
ABSTRACT
| FULL TEXT
Seprafilm May Ease Colostomy Reversal
Saribeyoglu et al.
Arch Surg 2004;139:1380-1382.
ABSTRACT
| FULL TEXT
Regulation of Postsurgical Fibrosis by the Programmed Death-1 Inhibitory Pathway
Holsti et al.
J. Immunol. 2004;172:5774-5781.
ABSTRACT
| FULL TEXT
Protective effect of ethyl-3-(3-dimethyl aminopropyl)urea dihydrochloride (EDU) against LPS-induced death in mice
Matsumoto et al.
J Med Microbiol 2004;53:97-102.
ABSTRACT
| FULL TEXT
Effect of Intraperitoneal Antiadhesive Fluids in a Rat Peritonitis Model
Muller et al.
Arch Surg 2003;138:286-290.
ABSTRACT
| FULL TEXT
|
